Skip to main content
OpenTrials

Clinical trial condition

Synucleinopathies

Explore clinical trials studying Synucleinopathies. Study availability and eligibility vary by location and protocol.

3,495 public trials 645 recruiting studies
Refine in advanced search Browse all conditions

Synucleinopathies trial results

Completed

An Open Label SLV308 Safety Extension to Study S308.3.002 in Patients With Parkinson's Disease Experiencing Motor Fluctuations.

NCT00407095

Conditions
Advanced Stage Parkinson's Disease, Basal Ganglia Diseases, Brain Diseases, +7 more
Locations
  • S308.3.007 Site # 220 La Jolla, California, United States
  • S308.3.007 Site # 211 San Francisco, California, United States
  • S308.3.007 Site # 214 Fort Lauderdale, Florida, United States
  • S308.3.007 Site # 218 Gainsville, Florida, United States
View all 87 locations
View Trial Details
Completed

Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's Disease

NCT00437125

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +12 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ancona, Italy
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Brescia, Italy
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Catania, Italy
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Genova, Italy
View all 13 locations
View Trial Details
Completed

A Trial of MitoQ for the Treatment of People With Parkinson's Disease

NCT00329056

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations
  • Westmead Hospital Sydney, New South Wales, Australia
  • The Royal Brisbane and Women's Hospital Brisbane, Queensland, Australia
  • Austin Hospital Melbourne, Victoria, Australia
  • Dunedin Hospital Dunedin, Otago, New Zealand
View all 13 locations
View Trial Details
Completed

Efficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease Patients, and Safety in Combination With L-dopa

NCT00582673

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +11 more
Locations
  • Novartis Investigator Site Dresden, Germany
  • Novartis Investigator Site Kassel, Germany
  • Novartis Investigator Site Leun, Germany
  • Novartis Investigator Site Marburg, Germany
View Trial Details

Related conditions